Catalyst Wire Dossier Catalyst Wire Dossier

Rabeprazole ER 50 mg

rabeprazole · Eisai
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rabeprazole ER 50 mg, covering 2013-11-01 to 2016-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD) [Phase 3]

See pricing